Oppenheimer Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $60

Futu News12:32 · Ratings

Corbus Pharmaceuticals | 10-Q: Quarterly report

SEC06:08 · Announcements

H.C. Wainwright Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $75

Futu News00:31 · Ratings

Express News | Corbus Pharmaceuticals Holdings Inc : RBC Cuts Target Price to $65 From $82

BreakingsNov 7 23:42

Corbus Pharmaceuticals Reports Q3 2024 Financial Results

TipRanksNov 7 22:02

Corbus Pharmaceuticals Had $159.4M in Cash, Cash Equivalents and Investments on Hand as of Sept 30 >CRBP

Dow JonesNov 7 20:02